Annual SG&A:
$428.89M+$38.02M(+9.73%)Summary
- As of today, NVCR annual SG&A is $428.89 million, with the most recent change of +$38.02 million (+9.73%) on December 31, 2024.
- During the last 3 years, NVCR annual SG&A has risen by +$165.71 million (+62.96%).
- NVCR annual SG&A is now at all-time high.
Performance
NVCR SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$104.47M+$3.45M(+3.41%)Summary
- As of today, NVCR quarterly SG&A is $104.47 million, with the most recent change of +$3.45 million (+3.41%) on September 30, 2025.
- Over the past year, NVCR quarterly SG&A has increased by +$4.53 million (+4.54%).
- NVCR quarterly SG&A is now -25.32% below its all-time high of $139.89 million, reached on December 31, 2024.
Performance
NVCR Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$4.84B-$177.65M(-3.81%)Summary
- As of today, NVCR TTM SG&A is -$4.84 billion, with the most recent change of -$177.65 million (-3.81%) on September 30, 2025.
- Over the past year, NVCR TTM SG&A has dropped by -$5.22 billion (-1347.84%).
- NVCR TTM SG&A is now -1649.38% below its all-time high of -$276.50 million.
Performance
NVCR TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
NVCR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +9.7% | +4.5% | -1347.8% |
| 3Y3 Years | +63.0% | +41.4% | -1775.4% |
| 5Y5 Years | +132.3% | +85.1% | -2336.4% |
NVCR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +63.0% | -25.3% | +41.4% | -70.8% | at low |
| 5Y | 5-Year | at high | +132.3% | -25.3% | +85.1% | -90.1% | at low |
| All-Time | All-Time | at high | +1199.3% | -25.3% | +1012.2% | -1649.4% | at low |
NVCR Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $104.47M(+3.4%) | $445.94M(+1.0%) |
| Jun 2025 | - | $101.02M(+0.5%) | $441.41M(+1.5%) |
| Mar 2025 | - | $100.56M(-28.1%) | $434.71M(+1.4%) |
| Dec 2024 | $428.89M(+9.7%) | $139.89M(+40.0%) | $428.89M(+10.6%) |
| Sep 2024 | - | $99.93M(+5.9%) | $387.63M(+0.0%) |
| Jun 2024 | - | $94.33M(-0.4%) | $387.55M(-1.3%) |
| Mar 2024 | - | $94.74M(-4.0%) | $392.49M(+0.4%) |
| Dec 2023 | $390.87M(+27.6%) | $98.64M(-1.2%) | $390.87M(+2.9%) |
| Sep 2023 | - | $99.85M(+0.6%) | $379.93M(+7.3%) |
| Jun 2023 | - | $99.27M(+6.6%) | $353.98M(+6.9%) |
| Mar 2023 | - | $93.11M(+6.2%) | $331.13M(+8.1%) |
| Dec 2022 | $306.41M(+16.4%) | $87.70M(+18.7%) | $306.41M(+6.1%) |
| Sep 2022 | - | $73.90M(-3.3%) | $288.70M(+3.6%) |
| Jun 2022 | - | $76.42M(+11.7%) | $278.61M(+3.5%) |
| Mar 2022 | - | $68.39M(-2.3%) | $269.09M(+2.2%) |
| Dec 2021 | $263.18M(+16.7%) | $69.99M(+9.7%) | $263.18M(+4.1%) |
| Sep 2021 | - | $63.81M(-4.6%) | $252.91M(+3.0%) |
| Jun 2021 | - | $66.90M(+7.1%) | $245.53M(+5.6%) |
| Mar 2021 | - | $62.48M(+4.6%) | $232.50M(+3.1%) |
| Dec 2020 | $225.45M(+22.1%) | $59.72M(+5.8%) | $225.46M(+4.2%) |
| Sep 2020 | - | $56.42M(+4.8%) | $216.29M(+4.8%) |
| Jun 2020 | - | $53.87M(-2.8%) | $206.40M(+4.5%) |
| Mar 2020 | - | $55.44M(+9.7%) | $197.50M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $184.62M(+22.2%) | $50.55M(+8.6%) | $184.62M(+5.9%) |
| Sep 2019 | - | $46.54M(+3.5%) | $174.34M(+5.2%) |
| Jun 2019 | - | $44.96M(+5.6%) | $165.78M(+4.8%) |
| Mar 2019 | - | $42.57M(+5.7%) | $158.23M(+4.7%) |
| Dec 2018 | $151.12M(+23.2%) | $40.28M(+6.0%) | $151.12M(+5.4%) |
| Sep 2018 | - | $37.98M(+1.5%) | $143.32M(+4.7%) |
| Jun 2018 | - | $37.40M(+5.5%) | $136.94M(+4.6%) |
| Mar 2018 | - | $35.46M(+9.2%) | $130.92M(+6.8%) |
| Dec 2017 | $122.64M(+11.0%) | $32.48M(+2.8%) | $122.64M(+3.2%) |
| Sep 2017 | - | $31.60M(+0.7%) | $118.84M(+2.6%) |
| Jun 2017 | - | $31.38M(+15.5%) | $115.82M(+3.3%) |
| Mar 2017 | - | $27.18M(-5.2%) | $112.07M(+1.5%) |
| Dec 2016 | $110.46M(+51.9%) | $28.68M(+0.3%) | $110.46M(+2.6%) |
| Sep 2016 | - | $28.59M(+3.5%) | $107.62M(+11.7%) |
| Jun 2016 | - | $27.63M(+8.1%) | $96.35M(+13.4%) |
| Mar 2016 | - | $25.56M(-1.1%) | $84.96M(+16.8%) |
| Dec 2015 | $72.72M(+60.8%) | $25.84M(+49.2%) | $72.72M(+55.1%) |
| Sep 2015 | - | $17.32M(+6.7%) | $46.88M(+58.6%) |
| Jun 2015 | - | $16.23M(+21.8%) | $29.56M(+14.8%) |
| Mar 2015 | - | $13.33M(+7.2%) | $25.76M(+18.0%) |
| Dec 2014 | $45.23M(+37.0%) | - | - |
| Jun 2014 | - | $12.43M(+32.3%) | $21.82M(+132.3%) |
| Mar 2014 | - | $9.39M | $9.39M |
| Dec 2013 | $33.01M | - | - |
FAQ
- What is NovoCure Limited annual SG&A?
- What is the all-time high annual SG&A for NovoCure Limited?
- What is NovoCure Limited annual SG&A year-on-year change?
- What is NovoCure Limited quarterly SG&A?
- What is the all-time high quarterly SG&A for NovoCure Limited?
- What is NovoCure Limited quarterly SG&A year-on-year change?
- What is NovoCure Limited TTM SG&A?
- What is the all-time high TTM SG&A for NovoCure Limited?
- What is NovoCure Limited TTM SG&A year-on-year change?
What is NovoCure Limited annual SG&A?
The current annual SG&A of NVCR is $428.89M
What is the all-time high annual SG&A for NovoCure Limited?
NovoCure Limited all-time high annual SG&A is $428.89M
What is NovoCure Limited annual SG&A year-on-year change?
Over the past year, NVCR annual SG&A has changed by +$38.02M (+9.73%)
What is NovoCure Limited quarterly SG&A?
The current quarterly SG&A of NVCR is $104.47M
What is the all-time high quarterly SG&A for NovoCure Limited?
NovoCure Limited all-time high quarterly SG&A is $139.89M
What is NovoCure Limited quarterly SG&A year-on-year change?
Over the past year, NVCR quarterly SG&A has changed by +$4.53M (+4.54%)
What is NovoCure Limited TTM SG&A?
The current TTM SG&A of NVCR is -$4.84B
What is the all-time high TTM SG&A for NovoCure Limited?
NovoCure Limited all-time high TTM SG&A is -$276.50M
What is NovoCure Limited TTM SG&A year-on-year change?
Over the past year, NVCR TTM SG&A has changed by -$5.22B (-1347.84%)